Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer

The immunosuppressive tumor microenvironment (TME) is the main reason for the failure of many immunotherapies that directly stimulate anti-tumor immune response. Anti-CTLA-4 antibody may reduce effector regulatory T (Treg) cell numbers and their suppressive activity in the TME. We have previously re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xuan, Chen, Hedan, Xie, Ying, Zhou, Xue, Wang, Yun, Zhou, Jing, Long, Shiqi, Hu, Zuquan, Zhang, Shichao, Qiu, Wei, Zeng, Zhu, Liu, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652013/
https://www.ncbi.nlm.nih.gov/pubmed/34875483
http://dx.doi.org/10.1016/j.tranon.2021.101298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652013/
https://www.ncbi.nlm.nih.gov/pubmed/34875483
http://dx.doi.org/10.1016/j.tranon.2021.101298

Ejemplares similares